Medicine® is a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties.
As an open access title, Medicine® will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine®'s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.
The APC for Medicine® is $1800 (USD) for the Creative Commons CCBY -NC license and $1950 for the Creative Commons CCBY license. The APC for Narrative Reviews is $1450 and will be published under the CCBY license. All Case Reports and Study Protocol articles will be published under the CCBY license. The APC for Case Reports and Study Protocols is $1950.
More information on Open Access: http://www.wkopenhealth.com/
Medicine offers full or partial equitable waivers for accepted articles from low-income and middle-income economies. Eligibility is based on the Research4Life eligibility criteria. Countries listed in Group A are eligible for the full waiver and countries listed in Group B are eligible for the partial (50%) waiver. The waiver is automatically applied based on the Corresponding Author's country information provided during submission.
Medicine® is indexed in:
- PubMed Central
- Europe PMC
- Directory of Open Access Journals (DOAJ)
- Web of Science
- ISI Journal Citation Reports
Medicine® article types are based upon key reporting guidelines, as defined by the EQUATOR Network. Authors should prepare their manuscripts in accordance with the appropriate guidelines(s) and/or checklist(s) for each type of article. We ask that you use the checklist and flow diagram templates for the guidelines outlined below available at
http://www.editorialmanager.com/md in the "Files & Resources" section of the home page. The appropriate checklist (and flow diagram, if applicable) must be included with each submission. For further information regarding reporting guidelines, authors should consult the EQUATOR Network web site (http://www.equator-network.org), which maintains a useful, up-to-date list of guidelines as they are published, with links to articles and checklists.
Peer review is an essential part of
decision process. All original material presented in
Medicine® undergoes rigorous multi-factorial single-blinded peer-review by carefully selecting dedicated and knowledgeable individuals who are experts in their field.
During the review process one of
Medicine®'s trusted Academic Editors are assigned the manuscript and takes responsibility for the review process. Academic Editors are asked to seek review from at least 2 external reviewers on any given manuscript.
Reviewers will be asked to respond to the following questions before submitting a review:Is the manuscript technically sound, and the data support the conclusion?Has the statistical analysis been performed appropriately and rigorously?Does the manuscript adhere to standards in this field for data availability?Is the manuscript presented in an intelligible fashion and written in standard English?Comments to the Author
Reviewers also ensure manuscripts meet the following criteria: The study and results are original researchThe paper has performed experiments with the highest ethical standardsThe paper has not been previously published in another journalThe paper adheres to the EQUATOR Network reporting guidelines
Medicine® expects the highest ethical standards from their authors, reviewers and editors when conducting research, submitting papers and throughout the peer-review process.
is a member of the Committee on Publishing Ethics (COPE) and follows their recommendations on publication ethics and standards. For additional information on COPE please visit
Redundant or duplicate publication
Duplicate or redundant publication is a publication that overlaps substantially with one already published, in press, or in an electronic media submission. (International Committee of Medical Journal Editors. http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html)
Duplicate or redundant submission is the same manuscript (or the same data) that is submitted to different journals at the same time. International copyright laws, ethical conduct, and cost effective use of resources require that readers can be assured that what they are reading is original. (International Council of Medical Journal Editors.
Submitted manuscripts should not have been published or currently submitted elsewhere. Duplicate publication is a violation of the APA code of ethics (APA Publication Manual, 2010) and will be grounds for prompt rejection of the submitted manus cript. If the editor was not aware of the violation and the article has been published, a notice of duplicate submission and the ethical violation will be published.
Conflicts of interest
At the point of submission, policy requires that each author reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition.
If the manuscript is accepted, Conflict of Interest information will be communicated in a published statement.
Permissions to reproduce previously published material
For permissions to reproduce, please see the license under which the individual article has been published. Articles published in Medicine® are published under any of the six Creative Commons International 4.0 Licenses.
Patient consent forms
The protection of a patient's right to privacy is essential. Please collect and keep copies of patients' consent forms on which patients or other subjects of your experiments clearly grant permission for the publication of photographs or other material that might identify them. If the consent form for your research did not specifically include this, please obtain it or remove the identifying material.
A statement to the effect that such consent had been obtained must be included in the 'Methods' section of your paper. If necessary the Editors may request a copy of any consent forms.
Ethics committee approval
All articles dealing with original human or animal data must include a statement on ethics approval at the beginning of the Methods section. This paragraph must contain the following information: the name and address of the ethics committee responsible; the protocol number that was attributed by this ethics committee; and the date of approval by the ethics committee.
The paragraph could read, for example:
"Ethical approval for this study (Ethical Committee N° NAC 207) was provided by the Ethical Committee NAC of Geneva University Hospitals, Geneva, on 12 February 2007."
In addition and as stated above, for studies conducted on human participants you must state clearly that you obtained written informed consent from the study participants; please also look at the latest version of the Declaration of Helsinki. If ethics clearance was not necessary, or if there was any deviation from these standard ethical requests, please state why it was not required. Please note that the editors may ask you to provide evidence of ethical approval. If you have approval from a National Drug Agency (or similar) please state this and provide details, this can be particularly useful when discussing the use of unlicensed drugs.
More information on
Medicine®'s policies, instructions, and guidelines can be found in the
Medicine® Information for Authors instructions and guidelines.
All manuscripts should be submitted online on our Submission Platform.
Total submissions received: 9,071
Acceptance rate: 46%
Average time from date of submissions received to first decision: 77.5 days
Editorial OfficeCase Editor
Dr. Maya Saranathan
Translation, Rights & Licensing
2001 Market Street, Philadelphia, PA
LWW Business Offices
Two Commerce Square
2001 Market Street
Philadelphia, PA 19103
Advertising Representative (U.S.)
Name: Tom Pitofsky
Advertising Representative (Europe)
Name: Donaree Stephens
Phone: +44 (0)203 197 6512
Recruiting Representative (U.S.)
Name: Terry Paolino
Recruiting Representative (Europe)
Name: Donaree Stephens
Phone: +44 (0)203 197 6512
Reprints Representative (U.S.)
Name: Meredith Edelman
Reprints Representative (Europe)
Name: Donaree Stephens
For more information on advertising with Medicine, please click
For more information about reprints, please click